Evidence map›Paper›PMID 37231058›Full record

ArticleCancer gene therapy2023

Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention.

Felipe F Lamenza, Nathan M Ryan, Puja Upadhaya, Arham Siddiqui, Pete P Jordanides, Anna Springer, Peyton Roth, Hasan Pracha, O Hans Iwenofu, Steve Oghumu

Open access · greenAbstract read
In one paragraph

Article in Cancer gene therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Berries vs. Disease: Revenge of the Phytochemicals.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Felipe F LamenzaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Nathan M RyanDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0001-7210-1642
Puja UpadhayaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Arham SiddiquiDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Pete P JordanidesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Anna SpringerDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Peyton RothDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Hasan PrachaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
O Hans IwenofuDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Steve OghumuDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. oghumu.1@osu.edu.ORCID 0000-0001-5177-0652
The Ohio State University Wexner Medical Center · US

Funding

X chromosome inactivation in sex disparities to substance use disorderDP1DA054344 · NIDA · OHIO STATE UNIVERSITY · PI Steve Onyeka Oghumu · 2021 to 2026
$2.4M
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black RaspberriesK01CA207599 · NCI · OHIO STATE UNIVERSITY · PI OGHUMU, STEVE ONYEKA · 2017 to 2021
$715k
Defining the role of the oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomesR56DE030093 · NIDCR · OHIO STATE UNIVERSITY · PI OGHUMU, STEVE ONYEKA · 2021 to 2021
$561k
NCI NIH HHS K01 CA207599NIDA NIH HHS DP1 DA054344NIDCR NIH HHS R56 DE030093
6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a significant public health problem, with a need for novel approaches to chemoprevention and treatment. Preclinical models that recapitulate molecular alterations that occur in clinical HNSCC patients are needed to better understand molecular and immune mechanisms of HNSCC carcinogenesis, chemoprevention, and efficacy of treatment. We optimized a mouse model of tongue carcinogenesis with discrete quantifiable tumors via conditional deletion of Tgfβr1 and Pten by intralingual injection of tamoxifen. We characterized the localized immune tumor microenvironment, metastasis, systemic immune responses, associated with tongue tumor development. We further determined the efficacy of tongue cancer chemoprevention using dietary administration of black raspberries (BRB). Three Intralingual injections of 500 µg tamoxifen to transgenic K14 Cre, floxed Tgfbr1, Pten (2cKO) knockout mice resulted in tongue tumors with histological and molecular profiles, and lymph node metastasis similar to clinical HNSCC tumors. Bcl2, Bcl-xl, Egfr, Ki-67, and Mmp9, were significantly upregulated in tongue tumors compared to surrounding epithelial tissue. CD4+ and CD8 + T cells in tumor-draining lymph nodes and tumors displayed increased surface CTLA-4 expression, suggestive of impaired T-cell activation and enhanced regulatory T-cell activity. BRB administration resulted in reduced tumor growth, enhanced T-cell infiltration to the tongue tumor microenvironment and robust antitumoral CD8+ cytotoxic T-cell activity characterized by greater granzyme B and perforin expression. Our results demonstrate that intralingual injection of tamoxifen in Tgfβr1/Pten 2cKO mice results in discrete quantifiable tumors suitable for chemoprevention and therapy of experimental HNSCC.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsTongue NeoplasmsAnimalsCarcinogenesisChemopreventionMiceMice, KnockoutSquamous Cell Carcinoma of Head and NeckTamoxifenTongueTumor MicroenvironmentTamoxifen

Identifiers

PMID37231058
PMCPMC10754272
OpenAlexW4378231845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.